Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Human Growth Hormone Therapy and Drug Metabolism

NCT00458991 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT00458991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Human Growth Hormone Therapy and Drug Metabolism
Lead sponsor
University of Louisville
Phase
Observational
Overall status
Completed
Start date
June 30, 2001
Completion date
September 30, 2008
Enrollment
9 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency, dwarfism